Summary.-Terminal deoxynucleotidyl transferase (TdT) was estimated in the tissues of 42 patients with lymphoma, whose cells were also typed by the use of surface markers. Four of the 8 patients with T-cell lymphoma were TdT+ including patients whose lymph nodes showed an undifferentiated or poorly differentiated appearance. The TdT-T-cell lymphomas included cases with diffuse histiocytic, Sezary cell, diffuse, poorly differentiated and angio-immunoblastic histology.
TERMINAL deoxynucleotidyl transferase (TdT) is an enzyme normally present in human marrow and thymus. The enzyme is present in 1-5% of murine marrow cells (Pazmino et al., 1977) and is restricted to the immature cortisone-sensitive fraction of thymic lymphocytes. The enzyme has also been found in the cells of patients with non-T, non-B, acute lymphoblastic leukaemia (ALL), T-cell ALL, and of some patients with blast transformation of chronic granulocytic leukaemia (CGL), but is usually absent in other types of leukaemia (McCaffrey et al., 1973; 1975; Coleman et al., 1974 Coleman et al., , 1976 Sarin et al., 1976; Hoffbrand et al., 1977 ). It appears therefore that the enzyme is present in the pluripotential marrow stem cell and is lost as cells mature down the myeloid or lymphoid pathways, being retained only in thymocytes. In lymphoma, TdT has only been detected in tumours of "lymphoblastic" histology (Donlon et al., 1977; Kung et al., 1978) . In the present study we report the TdT activity in the tissues of patients with lymphoma in which the surface phenotype of the cells has been established by tests of sheep-cell rosettes and surface immunoglobulin and complement (C3) receptors and by antibodies to non-B, non-T ALL (anti-ALL), to T-ALL (anti-HTLA), and the Ia antigen. The results show that the more common B-cell lymphomas and Hodgkin's tissues are normally TdT-whereas some but not all T-cell lymphomas are TdT+.
PATIENTS, MATERIALS AND METHODS
Material consisted of tumour-cell populations obtained from lymph nodes (36), tonsil (1), spleen (1), marrow (2), pleural effusion (2) and blood (1) showing sarcoid reaction) and adult thymus and tumour from a case of neuroblastoma was also tested. After mononuclear cell separation, the cells in each case were surface-marked using sheep erythrocytes for E, using ox red cells for Fe and C3 receptors, and for surfacemembrane immunoglobulin (SIg). Using polyvalent anti-human G, M and A heavy-chain antisera, the proportions of capping and noncapping cells were determined after appropriate incubation (Habeshaw et al., 1977 for up to 3 weeks before TdT estimation as previously described (Hoffbrand et al., 1977) .
RESULTS

Control tissues
TdT levels in control tissues ranged from 0 0 to 14 u/108 cells (tonsil I 1, blood 05, reactive nodes (2) 0 0, neuroblastoma 01). In one positive control thymus the TdT level was 117 0 U/l08 cells. Hodgkin's disease In 4 Hodgkin's disease lymph nodes, TdT levels ranged from 0-2 to 1-3 U/108 cells (3 lymphocyte predominant, and 1 nodular sclerosing histology). All 4 showed T-cell predominance (E+ 43-63%) with an accompanying polyclonal B cell population (18 %-29% SIg+).
TdT+ tumours
Four patients showed TdT levels ranging from 6-6 to 51 U/108 cells in the biopsied tissues (Table I ). The only adult (Case 4) had a lesion containing numerous epithelial (Table III) . Tdr elevated in either tissue.
B-cell tumours
The remaining tumours were mainly (over 80%) or entirely expressing monoclonal surface globin (Table III) (Habeshaw et al., 1977) .
Nevertheless, these cells were always 3 07
TdT-. Lonoclonal B-cell tumours were invariably TdT-.
Ixpressing One TdT+ SIg+ B-cell lymphoblastic 3nt (Table leukaemia has been described (Shaw et al., e propor-1978) . TdT was also detected in the cells expressed of a patient with pre-B-cell lymphoblastic F was not leukaemia (Vogler et al., 1978) . As in previously published reports (Donlon et al., 1977; Kung et al., 1978) , we have found TdT activity to occur in undifferentiated composed lymphomas of T-cell type. The phenotype of B cells of these tumours corresponds to those immuno-described for T-ALL (E+HTLA+la-) invariably . One of our tumours Ltients, in-of T cells, classified histologically as Lntial pro-diffuse poorly differentiated lymphocytic s. Surface lymphoma, was also TdT+ (Case 2). The "org"non-TdT-T-cell lymphomas showed a variety caps are of histology; one was undifferentiated. i 20 min
In the data of Kung et al. (1978) several are com-cases of E+C3+ T-cell tumours with TdT re usually positivity are described. In the single case tumours presented here with this surface phenoss Fc and/ type, the tumour was TdT-. Our failure to find TdT activity in B-cell lymphomas of all histological types corresponds to previously published findings (Donlon et al., 1977; Kung et al., 1978) . Lymphomas of SIg+ cells seem to be derived from differentiated, immunologically competent B-cell populations. Lymphomas expressing SIg and C3d receptors are derived from germinal centre B lymphocytes (Stein et al., 1978) . Capping SIg+ B cells including those with cytoplasmic Ig are associated with medullary-cord lymphocytes in normal nodes, and the phenotype Slg+Fc+C3+ may characterize the "virgin" B-cell population. Non-capping Slg+Fc-C3-tumours suggest a primitive or "transformed" B-cell tumour. The fact that lymphoid tumours expressing these phenotypes are all TdT-suggests TdT is lost early in B-cell differentiation.
